Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
Pharmacology, Toxicology and Pharmaceutical Science
10
7%
Agricultural and Biological Sciences
7
5%
Other
10
7%
Unknown
58
41%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2021.
All research outputs
#5,575,656
of 26,414,132 outputs
Outputs from Frontiers in immunology
#6,173
of 33,172 outputs
Outputs of similar age
#97,091
of 355,684 outputs
Outputs of similar age from Frontiers in immunology
#133
of 603 outputs
Altmetric has tracked 26,414,132 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,172 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 603 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.
